Clinical Trial Update: A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3 [Phase 4]

View source ↗

Summary

Phase 4 trial update for an individualized treatment approach in chronic hepatitis C patients (Genotype 2/3) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Kirby Institute | Conditions: Hepatitis C, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2017-10-18